| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |